share_log

艾美疫苗：於2024年5月20日舉行之股東週年大會適用的H股股東代表委任表格

AIM VACCINE: FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 20, 2024

Hong Kong Stock Exchange ·  Apr 25 05:42
Summary by Moomoo AI
艾美疫苗股份有限公司將於2024年5月20日上午十時在中國上海市浦東新區舉行股東週年大會。會議將審議包括2023年度董事會報告、監事會報告、年報、經審計財務報表、利潤分配方案及財務決算案在內的多項普通決議案。此外，會上還將討論特別決議案，包括授權董事會購回不超過已發行H股股份總數10%的H股，以及授權董事會發行不超過已發行股份總數20%的新股份。股東將通過代表委任表格指定代表或親自出席會議並投票。該代表委任表格需於會議前至少24小時送達指定地點，方為有效。
艾美疫苗股份有限公司將於2024年5月20日上午十時在中國上海市浦東新區舉行股東週年大會。會議將審議包括2023年度董事會報告、監事會報告、年報、經審計財務報表、利潤分配方案及財務決算案在內的多項普通決議案。此外，會上還將討論特別決議案，包括授權董事會購回不超過已發行H股股份總數10%的H股，以及授權董事會發行不超過已發行股份總數20%的新股份。股東將通過代表委任表格指定代表或親自出席會議並投票。該代表委任表格需於會議前至少24小時送達指定地點，方為有效。
EME VACCINES CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON MAY 20, 2024 AT 10:00 A.M. IN PUDONG NEW DISTRICT, SHANGHAI, CHINA. The meeting will consider a number of ordinary resolutions including the 2023 Board Report, Board of Supervisors Report, Annual Report, Audited Financial Statements, Profit Distribution Solutions and Financial Resolution. IN ADDITION, SPECIAL RESOLUTIONS WILL BE DISCUSSED AT THE MEETING, INCLUDING AUTHORIZING THE BOARD TO REPURCHASE NO MORE THAN 10% OF THE TOTAL NUMBER OF H SHARES ISSUED AND AUTHORIZING THE BOARD TO ISSUE NEW SHARES NOT EXCEEDING 20% OF THE TOTAL NUMBER OF SHARES ISSUED. Shareholders will appoint representatives by means of a proxy form or attend the meeting and vote in person. The proxy form must be delivered at the designated location at least 24 hours prior to the meeting in order to be valid.
EME VACCINES CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON MAY 20, 2024 AT 10:00 A.M. IN PUDONG NEW DISTRICT, SHANGHAI, CHINA. The meeting will consider a number of ordinary resolutions including the 2023 Board Report, Board of Supervisors Report, Annual Report, Audited Financial Statements, Profit Distribution Solutions and Financial Resolution. IN ADDITION, SPECIAL RESOLUTIONS WILL BE DISCUSSED AT THE MEETING, INCLUDING AUTHORIZING THE BOARD TO REPURCHASE NO MORE THAN 10% OF THE TOTAL NUMBER OF H SHARES ISSUED AND AUTHORIZING THE BOARD TO ISSUE NEW SHARES NOT EXCEEDING 20% OF THE TOTAL NUMBER OF SHARES ISSUED. Shareholders will appoint representatives by means of a proxy form or attend the meeting and vote in person. The proxy form must be delivered at the designated location at least 24 hours prior to the meeting in order to be valid.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more